Smitha Jagadish

Smitha Jagadish is a prominent figure in the pharmaceutical industry, currently leading the rare diseases division at Bial, a Portuguese pharmaceutical company. She is known for her commitment to advancing therapies for rare diseases and played a crucial role in Bial's recent partnership with the Orphan Therapeutics Accelerator (OTXL), aiming to revive the development of promising clinical-stage drugs that were previously shelved. Her work emphasizes the importance of innovative solutions in addressing the challenges faced by patients with rare conditions.